HIGHLAND CAPITAL MANAGEMENT LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q1 2019$480,000
+31.5%
25,0000.0%0.03%
+57.9%
Q1 2018$365,000
-67.8%
25,000
-64.3%
0.02%
-63.5%
Q4 2017$1,132,000
+101.4%
70,000
-49.4%
0.05%
+372.7%
Q2 2015$562,000
-57.6%
138,400
-60.0%
0.01%
-59.3%
Q1 2015$1,325,000346,0900.03%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders